Zhou Nan, Liu Yu-Da, Zhang Yue, Gu Ting-Wei, Peng Li-Hua
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China.
Pharmaceutics. 2023 May 9;15(5):1443. doi: 10.3390/pharmaceutics15051443.
Collagen has been widely applied as a functional biomaterial in regulating tissue regeneration and drug delivery by participating in cell proliferation, differentiation, migration, intercellular signal transmission, tissue formation, and blood coagulation. However, traditional extraction of collagen from animals potentially induces immunogenicity and requires complicated material treatment and purification steps. Although semi-synthesis strategies such as utilizing recombinant or expression systems have been explored as alternative methods, the influence of unwanted by-products, foreign substances, and immature synthetic processes have limited its industrial production and clinical applications. Meanwhile, macromolecule collagen products encounter a bottleneck in delivery and absorption by conventional oral and injection vehicles, which promotes the studies of transdermal and topical delivery strategies and implant methods. This review illustrates the physiological and therapeutic effects, synthesis strategies, and delivery technologies of collagen to provide a reference and outlook for the research and development of collagen as a biodrug and biomaterial.
胶原蛋白作为一种功能性生物材料,通过参与细胞增殖、分化、迁移、细胞间信号传递、组织形成和血液凝固等过程,已被广泛应用于调节组织再生和药物递送。然而,传统的从动物身上提取胶原蛋白的方法可能会引发免疫原性,并且需要复杂的材料处理和纯化步骤。尽管已经探索了利用重组或表达系统等半合成策略作为替代方法,但不需要的副产物、外来物质和不成熟的合成过程的影响限制了其工业化生产和临床应用。同时,大分子胶原蛋白产品在通过传统的口服和注射载体进行递送和吸收时遇到了瓶颈,这推动了透皮和局部递送策略以及植入方法的研究。本文综述了胶原蛋白的生理和治疗作用、合成策略以及递送技术,为胶原蛋白作为生物药物和生物材料的研发提供参考和展望。